The influence of alcohol, propylene glycol and 1,2-pentanediol on the permeability of hydrophilic model drug through excised pig skin

International Journal of Pharmaceutics

Volumn 374, Issue 1-2, 2009, Pages 39-45

  Duracher, Lucie ^a,b   Blasco, Laurent ^b   Hubaud, Jean Claude ^b   Vian, Laurence ^a   Marti Mestres, Gilberte ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b DIPTA   (France)

Author keywords

Caffeine; Enhancement; In vitro; Percutaneous penetration; Porcine membrane

Indexed keywords

1,2 PENTANEDIOL; ALCOHOL; CAFFEINE; PENETRATION ENHANCING AGENT; PROPYLENE GLYCOL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DIFFUSION; DRUG PENETRATION; DRUG TISSUE LEVEL; HYDROPHILICITY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SKIN PENETRATION; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; CAFFEINE; CHEMISTRY, PHARMACEUTICAL; ETHANOL; EXCIPIENTS; GLYCOLS; PERMEABILITY; PROPYLENE GLYCOL; SKIN ABSORPTION; SWINE; VEHICLES; WATER;

EID: 67349132476     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.02.021     Document Type: Article

References (60)

1. Bach M., and Lippold B.C. Percutaneous penetration enhancement and its quantification. Eur. J. Pharm. Biopharm. 46 (1998) 1-13
2. Barry B. Dermatological Formulations: Percutaneous Absorption (1983), Marcel Dekker, New York
3. Barry B. Mode of action of penetration enhancers in human skin. J. Control. Release 6 (1987) 85-97
4. Barry B. LPP theory of skin penetration enhancement. J. Control. Release 15 (1991) 237-248
5. Barry B. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 14 (2001) 101-114
6. Barry B., and Bennett S. Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J. Pharm. Pharmacol. 39 (1987) 535-546
7. Bhatia K.S., Gao S., and Singh J. Effect of penetration enhancers and iontophoresis on the FT-IR spectroscopy and LHRH permeability through porcine skin. J. Control. Release 47 (1997) 81-89
8. Bommannan D., Potts R., and Guy R. Examination of the effect of ethanol on human stratum corneum in vivo using infra red spectroscopy. J. Control. Release 16 (1991) 299-304
9. Boucaud A., Machet L., Arbeille B., Machet M., Sournac M., Mavon A., Patat F., and Vaillant L. In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin. Int. J. Pharm. 228 (2001) 69-77
10. Chan T.C. Percutaneous penetration enhancers: An update. 9th Biennial International Conference of Perspectives in Percutaneous Penetration (2005)
11. Clarys P., Gabard B., Lambrecht R., Barel A., Bieli E., and Ludi S. There is no influence of a temperature rise on in vivo adsorption of UV filters into the stratum corneum. J. Dermatol. Sci. 27 (2001) 77-81
12. Cole L., and Heard C. Skin permeation enhancement potential of Aloe Vera and a proposed mechanism of action based upon size exclusion and pull effect. Int. J. Pharm. 333 (2007) 10-16
13. Daniels R. Strategies for Skin Penetration Enhancement, New York. Skin Care Forum (2004)
14. Dias M., Farinha A., Faustino E., Hadgraft J., Pais J., and Toscano C. Topical delivery of caffeine from some commercial formulations. Int. J. Pharm. 182 (1999) 41-47
15. Fernandez C., Marti-Mestres G., Mestres J.P., and Maillols H. LC analysis of benzophenone-3 in pigskin and in saline solution-Application to determination of in vitro skin penetration. J. Pharm. Biomed. Anal. 22 (2000) 393-402
16. Fernandez C., Marti-Mestres G., Ramos J., and Maillols H. LC analysis of benzophenone-3: II application to determination of 'in vitro' and 'in vivo' skin penetration from solvents, coarse and submicron emulsions. J. Pharm. Biomed. Anal. 24 (2000) 155-165
17. Finnin B.C., and Morgan T.M. Transdermal penetration enhancers: Applications, limitations, and potential. J. Pharm. Sci. 88 (1999) 955-958
18. Franz T. Percutaneous absorption-Relevance of in vitro data. J. Invest. Dermatol. 64 (1975) 190-195
19. Goodman M., and Barry B. Lipid-protein-partitioning (LPP) theory of skin enhancer activity: finite dose technique. Int. J. Pharm. 57 (1989) 29-40
20. Greaves L.C., Wilkinson S.C., and Williams F.M. Factors affecting percutaneous absorption of caffeine in vitro. Toxicology 178 (2002) 65-66
21. Guy R. Iontophoresis-recent developments. J. Pharm. Pharmacol. 50 (1998) 371-374
22. Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int. J. Pharm. 184 (1999) 1-6
23. Harmonised tripartite guideline, I.C.H., 1996. Validation of analytical procedures: text and methodology. Recommended for adoption at Step 4 of the ICH process by the ICH Steering Committee, pp. 8-18.
24. Heard C.M., and Screen C. Probing the permeation enhancement of mefenamic acid by ethanol across full-thickness skin, heat-separated epidermal membrane and heat-separated dermal membrane. Int. J. Pharm. 349 (2008) 323-325
25. Herkenne C., Naik A., Kalia Y., Hadgraft J., and Guy R. Effect of propylene glycol on ibuprofen absorption into human skin in vivo. J. Pharm. Sci. 97 (2008) 185-197
26. Ho H.O., Chen L.C., Lin H.M., and Sheu M.T. Penetration enhancement by menthol combined with a solubilization effect in a mixed solvent system. J. Control. Release 51 (1998) 301-311
27. Hori M., Satoh S., and Maibach H.I. Classification of percutaneous enhancers-A conceptional diagram. J. Pharm. Pharmacol. 42 (1990) 71-72
28. Jiang R., Roberts M.S., Collins D.M., and Benson H.A.E. Absorption of sunscreens across human skin: an evaluation of commercial products for children and adults. Br. J. Clin. Pharmacol. 48 (1999) 635-637
29. Jimenez M.M., Pelletier J., Bobin M.F., and Martini M.C. Influence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamate. Int. J. Pharm. 272 (2004) 45-55
30. Kim C., Shim J., Han S., and Chang I. The skin-permeation-enhancing effect of phosphatidylcholine: Caffeine as a model active ingredient. J. Cosmet. Sci. 53 (2002) 363-374
31. Kim Y.-C., Park J.-H., Ludovice P.J., and Prausnitz M.R. Synergistic enhancement of skin permeability by N-lauroylsarcosine and ethanol. Int. J. Pharm. 352 (2008) 129-138
32. Kligman A., and Christophers E. Preparation of isolated sheets of human stratum corneum. Arch. Dermatol. 88 (1963) 702-770
33. Krill S.L., Knutson K., and Higuchi W.I. Ethanol effects on the stratum corneum lipid phase-behavior. Biochem. Biophys. Acta 1112 (1992) 273-280
34. Kurul E., and Hekimoglu S. Skin permeation of two different benzophenone derivatives from various vehicles. Int. J. Cosmet. Sci. 23 (2001) 211-218
35. Meylan W.M., and Howard P.H. Atom/fragment contribution method for estimating octanol-water partition coefficients. J. Pharm. Sci. 84 (1995) 83-92
36. Monti D., Giannelli R., Chetoni P., and Burgalassi S. Comparison of the effect of ultrasound and of chemical enhancers on transdermal permeation of caffeine and morphine through hairless mouse skin in vitro. Int. J. Pharm. 229 (2001) 131-137
37. Moser K., Kriwet K., Naik A., Kalia Y.N., and Guy R.H. Passive skin penetration enhancement and its quantification in vitro. Eur. J. Pharm. Biopharm. 52 (2001) 103-112
38. Nangia A., Patil S., Berner B., Boman A., and Maibach H.I. In vitro measurementof transepidermal water loss: a rapid alternative to tritiated water permeation for assessing skin barrier function. Int. J. Pharm. 170 (1998) 33-40
39. OECD, 2000. Draft guidance document for the conduct of skin absorption studies. Series on Testing and assessment no. 28.
40. OECD, 2000. Guideline for the testing of chemicals. Skin absorption: in vitro method. Draft Guideline 428.
41. Ota Y., Hamada A., Nakano M., and Saito H. Evaluation of percutaneous absorption of midazolam by terpenes. Drug Metab. Pharmacokinet. 18 (2003) 261-266
42. Panchagnula R., Salve P.S., Thomas N.S., Jain A.K., and Ramarao P. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int. J. Pharm. 219 (2001) 95-105
43. Potts R.O., Golden G.M., Francoeur M.L., Mak V.H.W., and Guy R.H. Mechanism and enhancement of solute transport across the stratum-corneum. J. Control. Release 15 (1991) 249-260
44. Pugh W.J., Wong R., Falson F., Michniak B.B., and Moss G.P. Discriminant analysis as a tool to identify compounds with potential as transdermal enhancers. J. Pharm. Pharmacol. 57 (2005) 1389-1396
45. Ranade V.V. Drug delivery system. 6: transdermal drug delivery. J. Clin. Pharmacol. 31 (1991) 401-418
46. Rougier A., Dupuis D., Lotte C., Roguet R., and Schaefer H. In vivo correlation between stratum-corneum reservoir function and percutaneous-absorption. J. Invest. Dermatol. 81 (1983) 275-278
47. SCCP, 2006. Opinion for Basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients, 1-12.
48. Scheuplein R., and Blank I. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J. Invest. Dermatol. 60 (1973) 286-296
49. Skelly J., Shah V., Maibach H., Guy R.H., Flynn G., and Yacobi A. FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavaliability and bioequivalence. Pharm. Res. 4 (1987) 265-267
50. Smith E.W., and Maibach H.I. Future perspectives for penetration enhancers. Percutaneous Penetration Enhancers (1995) 481-484
51. Statgraphics. Plus for Windows, Version 5.1 (2001), Manugistics Inc., Maryland, USA
52. Tata S., Weiner N., and Flynn G. Relative influence of ethanol and propylene glycol cosolvents on deposition of minoxidil into the skin. J. Pharm. Sci. 83 (1994) 1508-1510
53. Trottet L., Merly C., Mirza M., Hadgraft J., and Davis A.F. Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride. Int. J. Pharm. 274 (2004) 213-219
54. van de Sandt J.J.M., van Burgsteden J.A., Cage S., Carmichael P.L., Dick I., Kenyon S., Korinth G., Larese F., Limasset J.C., Maas W.J.M., Montomoli L., Nielsen J.B., Payan J.P., Robinson E., Sartorelli P., Schaller K.H., Wilkinson S.C., and Williams F.M. In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. Regul. Toxicol. Pharmacol. 39 (2004) 271-281
55. Walker R., and Smith E. The role of percutaneous penetration enhancers. Adv. Drug Deliv. Rev. 18 (1996) 295-301
56. Weigmann H.J., Lademann J., Schanzer S., Lindemann U., Von Pelchrzim R., Schaefer H., Sterry W., and Shah V. Correlation of the local distribution of topically applied substances inside the stratum corneum determined by tape-stripping to differences in bioavailability. Skin Pharmacol. Appl. Skin Physiol. 14 (2001) 98-102
57. Wilkinson S., Mass W., Nielsen J., Greaves L., Van De Sandt J., and Williams F. Influence of skin thickness on percutaneous penetration in vitro. Int. Arch. Occup. Environ. Health 79 (2006) 405-413
58. Williams A., and Barry B. Penetration enhancers. Adv. Drug Deliv. Rev. 53 (2004) 603-618
59. Wu P.C., Huang Y.B., Fang J.Y., and Tsai Y.H. In vitro percutaneous absorption of captopril. Int. J. Pharm. 148 (1997) 41-46
60. Yum S., Lee E., Taskovich L., and Theeuwes F. Permeation enhancement with ethanol: mechanism of action through skin. Drug Permeation Enhancement 62 (1994) 143